GOLD 2024: a Brief Overview of Key Changes

Overview

Journal J Bras Pneumol

Specialty Pulmonary Medicine

Date 2023 Dec 21

PMID 38126685

Authors

Alvar Agusti

Claus F Vogelmeier

Affiliations

Soon will be listed here.

Citing Articles

Respiratory and physical health consequences in older adults in a high-risk volcanic area: Comparison of two rural villages.

Benavides-Cordoba V, Suarez A, Guerrero-Jaramillo D, Silva-Medina M, Betancourt-Pena J, Palacios-Gomez M PLoS One. 2024; 19(9):e0310659.

PMID: 39298450 PMC: 11412650. DOI: 10.1371/journal.pone.0310659.

References

Faner R, Cruz T, Agusti A . Immune response in chronic obstructive pulmonary disease. Expert Rev Clin Immunol. 2013; 9(9):821-33. DOI: 10.1586/1744666X.2013.828875. View

Criner G, Celli B, Brightling C, Agusti A, Papi A, Singh D . Benralizumab for the Prevention of COPD Exacerbations. N Engl J Med. 2019; 381(11):1023-1034. DOI: 10.1056/NEJMoa1905248. View

Reumkens C, Endres A, Simons S, Savelkoul P, Sprooten R, Franssen F . Application of the Rome severity classification of COPD exacerbations in a real-world cohort of hospitalised patients. ERJ Open Res. 2023; 9(3). PMC: 10204729. DOI: 10.1183/23120541.00569-2022. View

Miller M, Quanjer P, Swanney M, Ruppel G, Enright P . Interpreting lung function data using 80% predicted and fixed thresholds misclassifies more than 20% of patients. Chest. 2010; 139(1):52-9. DOI: 10.1378/chest.10-0189. View

Casanova C, Cote C, de Torres J, Aguirre-Jaime A, Marin J, Pinto-Plata V . Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004; 171(6):591-7. DOI: 10.1164/rccm.200407-867OC. View

Xie W, Kathuria H, Galiatsatos P, Blaha M, Hamburg N, Robertson R . Association of Electronic Cigarette Use With Incident Respiratory Conditions Among US Adults From 2013 to 2018. JAMA Netw Open. 2020; 3(11):e2020816. PMC: 7662143. DOI: 10.1001/jamanetworkopen.2020.20816. View

Crisafulli E, Sartori G, Huerta A, Gabarrus A, Fantin A, Soler N . Association Between Rome Classification Among Hospitalized Patients With COPD Exacerbations and Short-Term and Intermediate-Term Outcomes. Chest. 2023; 164(6):1422-1433. DOI: 10.1016/j.chest.2023.07.021. View

Wan E . The Clinical Spectrum of PRISm. Am J Respir Crit Care Med. 2022; 206(5):524-525. PMC: 9716910. DOI: 10.1164/rccm.202205-0965ED. View

Feldman R, Antonelli-Incalzi R, Steenackers K, Lee D, Papi A, Ison M . Respiratory Syncytial Virus Prefusion F Protein Vaccine Is Efficacious in Older Adults With Underlying Medical Conditions. Clin Infect Dis. 2023; 78(1):202-209. PMC: 10810713. DOI: 10.1093/cid/ciad471. View

10.

Wan E, Balte P, Schwartz J, Bhatt S, Cassano P, Couper D . Association Between Preserved Ratio Impaired Spirometry and Clinical Outcomes in US Adults. JAMA. 2021; 326(22):2287-2298. PMC: 8672237. DOI: 10.1001/jama.2021.20939. View

11.

Rose J, Menon A, Hino T, Hata A, Nishino M, Lynch D . Suspected Interstitial Lung Disease in COPDGene Study. Am J Respir Crit Care Med. 2022; 207(1):60-68. PMC: 9952869. DOI: 10.1164/rccm.202203-0550OC. View

12.

Mannino D, Buist A, Vollmer W . Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?. Thorax. 2006; 62(3):237-41. PMC: 2117148. DOI: 10.1136/thx.2006.068379. View

13.

Mannino D, Diaz-Guzman E . Interpreting lung function data using 80% predicted and fixed thresholds identifies patients at increased risk of mortality. Chest. 2011; 141(1):73-80. DOI: 10.1378/chest.11-0797. View

14.

Suissa S . Single-inhaler triple dual bronchodilator therapy for GOLD group E and other exacerbating patients with COPD: real-world comparative effectiveness and safety. Eur Respir J. 2023; 62(3). DOI: 10.1183/13993003.00883-2023. View

15.

Villar-Alvarez F, de la Rosa-Carrillo D, Farinas-Guerrero F, Jimenez-Ruiz C . Immunosenescence, Immune Fitness and Vaccination Schedule in the Adult Respiratory Patient. Open Respir Arch. 2023; 4(3):100181. PMC: 9109993. DOI: 10.1016/j.opresp.2022.100181. View

16.

Bhatt S, Sieren J, Dransfield M, Washko G, Newell Jr J, Stinson D . Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction. Thorax. 2013; 69(5):409-14. PMC: 4146523. DOI: 10.1136/thoraxjnl-2012-202810. View

17.

Stolz D, Mkorombindo T, Schumann D, Agusti A, Ash S, Bafadhel M . Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission. Lancet. 2022; 400(10356):921-972. PMC: 11260396. DOI: 10.1016/S0140-6736(22)01273-9. View

18.

Celli B, Fabbri L, Aaron S, Agusti A, Brook R, Criner G . An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal. Am J Respir Crit Care Med. 2021; 204(11):1251-1258. DOI: 10.1164/rccm.202108-1819PP. View

19.

Buhr R, Barjaktarevic I, Quibrera P, Bateman L, Bleecker E, Couper D . Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study. Am J Respir Crit Care Med. 2022; 206(5):554-562. PMC: 9716898. DOI: 10.1164/rccm.202201-0094OC. View

20.

Martinez F, Agusti A, Celli B, Han M, Allinson J, Bhatt S . Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre-Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward. Am J Respir Crit Care Med. 2021; 205(3):275-287. PMC: 8886994. DOI: 10.1164/rccm.202107-1663SO. View